+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Beta-Glucan Market Size was valued at USD 1.6 billion in 2022. The Beta-Glucan market Technology is projected to grow from USD1.8 billion in 2023 to USD 2.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period (2023 - 2032). Growing geriatric populations, increasing incidence of chronic disease, and rising product demand in functional food and animal feed applications are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Growing product demand in functional food and animal feed applications is likely to be a key market driver over the course of the projected timeframe. The rise in chronic diseases and the aging population are two major factors driving the need for functional foods worldwide. In developing countries, people have lower immunity levels more frequently, especially women and children. The aforementioned factors as well as rising consumer health consciousness are predicted to increase demand for drugs that promote immunity, including the product. Preventive programs are becoming more and more popular among consumers over post-treatment medications. The market for nutraceuticals and medicines containing yeast beta-glucan is expected to increase throughout the predicted period as a result of product advances, notably in the nutrition sector.
More than 75.0% of the North American market's volume was accounted for by the United States in 2021, and it is expected that this dominance would persist for the duration of the forecast period. High consumer spending on dietary supplements and functional food items is predicted to drive product demand in the country throughout the forecast period. Due to its ability to strengthen the immune system, the drug was among the substances that attracted the greatest interest throughout the outbreak. Unité de GlycobiologieStructuraleetFonctionnelle (UGSF) research from 2020 indicates that it helps to strengthen immune defense before a patient contracts respiratory virus infections, particularly SARS-CoV-2.
The global market was boosted by the nutraceutical industry's rapid rise on a global scale. Consumers are using innovative methods to achieve their nutritional demands by incorporating functional foods and other dietary supplements into their everyday diets. Consumers who choose a healthy diet, such as athletes, gym goers, and other health-conscious people, are rapidly growing the market for these food products with added nutrients.
Manufacturers of nutraceuticals are concentrating on creating a range of natural supplements with B-glucan infusions that will particularly strengthen the body's immune and digestive systems. The "go-green trend" and food ingredients produced from plants have become more and more popular around the world in recent years, which has led to an increase in the usage of B-glucan in manufacturing. The anticipated of the current situation and the increasing need for such nutrient-rich supplements will ensure B-glucan's future growth in the global market.
B-glucan is gaining popularity on a global scale because of its beneficial health properties, which have led to the expansion of its end-user usage in sectors like medicine and cosmetics. The producers must introduce more and varied forms of B-glucan to meet the end customers' growing demand. Oats are one of the most frequently used sources of B-glucan extraction globally. Oat production has substantially expanded recently all over the world, and this increased availability is one of the key factors driving companies to accelerate the production of B-glucan in the global market.Thus, driving the Beta-Glucan market revenue.
The global Beta-Glucan market segmentation, based on Source, includes yeast, mushroom, cereals, and microalgae. Yeast segment dominated the global market in 2022. Yeast is a preferred raw material for producers who want to extract beta-glucan for the market. Producers mainly offer a variety of yeast-derived B-glucan to their associated end-users, as opposed to other B-glucan sources on the market. The source and extraction of yeast B-glucan require careful attention and prevention throughout the process in order to minimize functional and nutritional disruption in the finished items. A result of the essential technological advancements in the yeast extraction process is the high price of beta-glucan on the market.
The global Beta-Glucan market segmentation, based on Application, includes food & beverages, animal feed, personal care, pharmaceuticals, and others.Food & beverages segment dominated the global market in 2022. It is projected that it will maintain its advantage throughout the forecast. The increasing use of functional foods and dietary supplements globally is estimated to be the primary factor driving market expansion over the anticipated timeframe. It is projected that the product's low price will be the primary element influencing demand in animal feed applications. Improved immunological function in animals, increased antibody titers after vaccination, and increased resistance to microbial infections are some of the product's key benefits.
The global Beta-Glucan market segmentation, based on Type, includes (1,3) beta-glucan, (1,4) beta-glucan, and (1,6) beta-glucan. (1,3) The beta-glucan segment dominated the global Beta-Glucan market in 2022. Comparing (1,4) and (1,6) beta-glucan to (1,3) beta-glucan, the global beta market favours (1,3) beta-glucan. Due to its simple extraction methods, most manufacturers include (1,3) beta glucan in their product lineup. These are frequently used in the manufacture of the fastest-growing industries, including medicines, cosmetics, and other personal care products.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. In 2022, this market was dominated by the North American beta-glucan market (45.80%). Among the top market players in the North American beta-glucan industry are American firms Merck and Lesaffre. These are thought to be the elements causing the rise in the area. Beta-glucan is currently widely employed in the food and beverage business as thickening agents, fat alternatives, dietary fiber, and hypocholesterolemic agents. Further, In the North American area, the U.S. Beta-Glucan market had the biggest market share, while the Canada Beta-Glucan market had the quickest rate of expansion.
Further, the major countries studied in the market report are The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
In 2022, the beta-glucan market in Europe held a sizable market share. Low-calorie and low-fat food items are popular throughout the continent because European consumers are calorie-conscious. Consumer demand for food products manufactured from natural, low-calorie ingredients has increased as a result of the rise in obesity and cardiovascular illnesses. Further, In the European region, the German Beta-Glucan market had the biggest market share, and the U.K. Beta-Glucan market had the quickest rate of growth.
From 2023 to 2032, the Asia Pacific beta-glucan market is anticipated to experience rapid growth. Numerous enterprises in Asia, including India, China, South Korea, and Japan, that produce food processing, cosmetics, and personal care items, are helping to meet the region's demand for goods. The region is quite different in terms of income, demography, and nutritional requirements. The rising demand for food products with better nutritional benefits and consumers' higher spending power are both expected to positively impact industry growth. Moreover, In the Asia-Pacific region, the Indian Beta-Glucan market had the quickest rate of growth while China's Beta-Glucan market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Beta-Glucan market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Beta-Glucan sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Beta-Glucan industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Beta-Glucan sector. Major players in the Beta-Glucan market, including Kerry Group plc., Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, BiotecPharmacon ASA, Tate & Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc., are attempting to increase market demand by investing in research and development operations.
Produced and distributed by Kemin Industries Inc. (Kemin), these compounds have a direct impact on both human and animal health. Enzymes, probiotics, carotenoids, natural extracts, mold inhibitors, forage preservatives, toxin binders, liquid antibacterial formulations, and antioxidant formulations are some of the products it offers. A wide range of industries employ these products, including biofuels, personal care, industrial greenhouses, pet food technology, rendering, dietary components, food technologies, and animal nutrition and health. In December 2022, Kemin Industry will increase the size of its production plant. The decision by Kemin to increase the size of its Cavriago production facility demonstrates the company's commitment to innovation and sustainability in animal nutrition and health.
Identifying environmental, social, and economic challenges and opportunities, seizing those opportunities to have a long-lasting positive impact on people and the environment, and then building growth through sustainable, profitable expansion, is the mission of Royal DSM NV (DSM), a science-based company. Specialty polymers, fiber and resin products, nutritious lipids, carotenoids, vitamins, and other components are produced by the company. The business manufactures materials for medical devices and renewable energy out of agricultural waste and biochemicals. In January 2022, the company announced the creation of an integrated food and beverage operational structure that combines three facets of DSM's nutrition business: Food Specialties, Hydrocolloids, and a section of its Nutritional Products Group.
· Kerry Group plc.
· Givaudan SA
· Koninklijke DSM N.V.
· Euglena Co. Ltd
· BiotecPharmacon ASA
· Tate & Lyle plc.
· Lesaffre Group
· Kemin Industries, Inc.
· ABF Ingredients
· Super Beta Glucan
· Garuda International, Inc.
June 2020: Lesaffre purchases a majority stake in the Chinese company Biohymn Biotechnology. An organization called Biohymn Biotechnology from China specializes in producing yeast and yeast extracts.
· Yeast
· Mushroom
· Cereals
· Microalgae
· Food & Beverages
· Animal Feed
· Personal Care
· Pharmaceuticals
· Others
· (1,3) Beta Glucan
· (1,4) Beta Glucan
· (1,6) Beta Glucan
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 1.6 Billion |
|
Market Size 2023 |
USD 1.8 Billion |
|
Market Size 2032 |
USD 2.4 Billion |
|
Compound Annual Growth Rate (CAGR) |
6.20% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Source, Application, Type, and Region |
|
Geographies Covered |
North America, Europe, AsiaPacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Kerry Group plc., Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, BiotecPharmacon ASA, Tate & Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc. |
|
Key Market Opportunities |
Untapped beta-glucan applications |
|
Key Market Dynamics |
Growing product demand in functional food and animal feed applications, the rising number of chronic diseases, and burgeoning geriatric population |
The global Beta-Glucan Market was valued at USD 1.6 billion in 2022, and it is estimated to reach USD 2.4 billion by 2032.
The global market is projected to grow at a CAGR of 6.20% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Kerry Group plc.,Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, BiotecPharmacon ASA, Tate & Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc.
The YeastSourcedominated the market in 2022.
The Food & BeveragesApplicationhad the largest share in the global market.
Report Code :
RL65123
Published on :
Sep 2023
Request a Free Sample Report
Speak to Analyst